Cargando…
[Retracted] Isoquercitrin inhibits the progression of liver cancer in vivo and in vitro via the MAPK signalling pathway
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018447/ https://www.ncbi.nlm.nih.gov/pubmed/36866771 http://dx.doi.org/10.3892/or.2023.8510 |
_version_ | 1784907810265366528 |
---|---|
author | Huang, Guihong Tang, Bo Tang, Kun Dong, Xiaomin Deng, Jungang Liao, Luqin Liao, Zengzhen Yang, Hua He, Songqing |
author_facet | Huang, Guihong Tang, Bo Tang, Kun Dong, Xiaomin Deng, Jungang Liao, Luqin Liao, Zengzhen Yang, Hua He, Songqing |
author_sort | Huang, Guihong |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10018447 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-100184472023-03-17 [Retracted] Isoquercitrin inhibits the progression of liver cancer in vivo and in vitro via the MAPK signalling pathway Huang, Guihong Tang, Bo Tang, Kun Dong, Xiaomin Deng, Jungang Liao, Luqin Liao, Zengzhen Yang, Hua He, Songqing Oncol Rep Retraction D.A. Spandidos 2023-02-28 /pmc/articles/PMC10018447/ /pubmed/36866771 http://dx.doi.org/10.3892/or.2023.8510 Text en Copyright: © Huang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited. |
spellingShingle | Retraction Huang, Guihong Tang, Bo Tang, Kun Dong, Xiaomin Deng, Jungang Liao, Luqin Liao, Zengzhen Yang, Hua He, Songqing [Retracted] Isoquercitrin inhibits the progression of liver cancer in vivo and in vitro via the MAPK signalling pathway |
title | [Retracted] Isoquercitrin inhibits the progression of liver cancer in vivo and in vitro via the MAPK signalling pathway |
title_full | [Retracted] Isoquercitrin inhibits the progression of liver cancer in vivo and in vitro via the MAPK signalling pathway |
title_fullStr | [Retracted] Isoquercitrin inhibits the progression of liver cancer in vivo and in vitro via the MAPK signalling pathway |
title_full_unstemmed | [Retracted] Isoquercitrin inhibits the progression of liver cancer in vivo and in vitro via the MAPK signalling pathway |
title_short | [Retracted] Isoquercitrin inhibits the progression of liver cancer in vivo and in vitro via the MAPK signalling pathway |
title_sort | [retracted] isoquercitrin inhibits the progression of liver cancer in vivo and in vitro via the mapk signalling pathway |
topic | Retraction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018447/ https://www.ncbi.nlm.nih.gov/pubmed/36866771 http://dx.doi.org/10.3892/or.2023.8510 |
work_keys_str_mv | AT huangguihong retractedisoquercitrininhibitstheprogressionoflivercancerinvivoandinvitroviathemapksignallingpathway AT tangbo retractedisoquercitrininhibitstheprogressionoflivercancerinvivoandinvitroviathemapksignallingpathway AT tangkun retractedisoquercitrininhibitstheprogressionoflivercancerinvivoandinvitroviathemapksignallingpathway AT dongxiaomin retractedisoquercitrininhibitstheprogressionoflivercancerinvivoandinvitroviathemapksignallingpathway AT dengjungang retractedisoquercitrininhibitstheprogressionoflivercancerinvivoandinvitroviathemapksignallingpathway AT liaoluqin retractedisoquercitrininhibitstheprogressionoflivercancerinvivoandinvitroviathemapksignallingpathway AT liaozengzhen retractedisoquercitrininhibitstheprogressionoflivercancerinvivoandinvitroviathemapksignallingpathway AT yanghua retractedisoquercitrininhibitstheprogressionoflivercancerinvivoandinvitroviathemapksignallingpathway AT hesongqing retractedisoquercitrininhibitstheprogressionoflivercancerinvivoandinvitroviathemapksignallingpathway |